Article

Research into biomarkers: how does drug procurement affect the design of clinical trials?

Paul Seabright

Mots-clés

clinical trials; biomarkers; pharmaceuticals; medical procurement;

Voir aussi

Publié dans

Health Management, Policy and Innovation, vol. 1, n° 3, juin 2013, p. 1–15